Case Report: Disseminated Tuberculosis After Kidney Transplantation

被引:1
作者
Hall, Ashton D. [1 ]
Huaman, Moises A. [1 ]
LaPorta, Joseph C. [2 ]
Luckett, Keith M. [1 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Internal Med, Div Infect Dis, 231 Albert Sabin Way, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH USA
关键词
LATENT TUBERCULOSIS; UNITED-STATES; RIFAPENTINE; INFECTION;
D O I
10.4269/ajtmh.23-0358
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Tuberculosis (TB) can cause significant morbidity and mortality among solid organ transplant (SOT) recipients, including disseminated disease. Most TB cases after SOT occur in kidney transplant recipients, although data about TB in this population are sparse. Tuberculosis may present atypically in immunocompromised patients, underscoring why physicians must maintain high clinical suspicion when pertinent epidemiological risk factors are present, including birth or former residence in a country with endemic TB. We describe a unique case of disseminated TB in a 54-year-old Filipino woman who developed central nervous system tuberculoma, Pott's disease, chorioretinitis, and a perinephric fluid collection after kidney transplantation. Despite being a preventable and curable disease, TB remains a relevant and challenging infection with complex diagnostic and treatment guidelines.
引用
收藏
页码:535 / 539
页数:5
相关论文
共 27 条
[1]   Donor derived Mycobacterium tuberculosis infection after solid-organ transplantation: A comprehensive review [J].
Abad, Cybele L. R. ;
Razonable, Raymund R. .
TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (05)
[2]   Mycobacterium tuberculosis after solid organ transplantation: A review of more than 2000 cases [J].
Abad, Cybele Lara R. ;
Razonable, Raymund R. .
CLINICAL TRANSPLANTATION, 2018, 32 (06)
[3]   Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis? [J].
Alfarisi, Omamah ;
Alghamdi, Wael A. ;
Al-Shaer, Mohammad H. ;
Dooley, Kelly E. ;
Peloquin, Charles A. .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (10) :1027-1036
[4]  
Anand Manish, 2017, World J Transplant, V7, P213, DOI [10.5500/wjt.v7.i3.213, 10.5500/wjt.v7.i3.213]
[5]  
Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P333
[6]   Prevention and management of tuberculosis in solid organ transplantation: A consensus statement of the transplantation society of Taiwan [J].
Chiang, Chen-Yuan ;
Chen, Cheng-Hsu ;
Feng, Jia-Yih ;
Chiang, Yang-Jen ;
Huang, Wei-Chang ;
Lin, Yih-Jyh ;
Huang, Yi-Wen ;
Wu, Hsin-Hsu ;
Lee, Pin-Hui ;
Lee, Ming-Che ;
Shu, Chin-Chung ;
Wang, Hsu-Han ;
Wang, Jann-Yuan ;
Wu, Mei-Yi ;
Lee, Chih-Yuan ;
Wu, Mai-Szu .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (10) :976-985
[7]  
Clemente WT, 2021, Case Rep Transplant, V2021, DOI 101155/2021/8816426
[8]   Short-Course Isoniazid Plus Rifapentine Directly Observed Therapy for Latent Tuberculosis in Solid-Organ Transplant Candidates [J].
de Castilla, Diego Lopez ;
Rakita, Robert M. ;
Spitters, Christopher E. ;
Narita, Masahiro ;
Jain, Rupali ;
Limaye, Ajit P. .
TRANSPLANTATION, 2014, 97 (02) :206-211
[9]  
Filardo TD, 2022, MMWR-MORBID MORTAL W, V71, P441, DOI 10.15585/mmwr.mm7112a1
[10]   Factors Associated With Latent Tuberculosis Infection Treatment Failure Among Patients With Commercial Health Insurance-United States, 2005-2016 [J].
Iqbal, Shareen A. ;
Isenhour, Cheryl J. ;
Mazurek, Gerald ;
Langer, Adam J. ;
Chang, Man-Huei ;
Truman, Benedict I. .
JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2021, 27 (04) :E151-E161